Journal
EXPERT REVIEW OF VACCINES
Volume 10, Issue 2, Pages 211-226Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.10.161
Keywords
analogue; epitope; MHC; peptide; peptidomimetic; TCR; vaccine
Categories
Funding
- Australian Research Council [LP0883541]
- National Health and Medical Research Council of Australia [508927, 508929]
- Australian Research Council [LP0883541] Funding Source: Australian Research Council
Ask authors/readers for more resources
Peptide vaccines represent a potential strategy for the prevention and treatment of pathogenic diseases, cancers and autoimmune disorders; their low cost, ease of synthesis and inherent safety are all attractive features. However, they have remained largely unsuccessful owing to low immunogenicity, predominantly stemming from reduced bioavailability due to rapid proteolytic degradation in vivo. The field of peptidomimetics, through chemical alteration of epitope structure, attempts to modify peptides to engender improved immunogenicity and stability, with the ultimate aim of rationally designing more efficacious vaccines. This article discusses the strategies employed in this process and recent advances within the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available